Clinical Trial Update: PFAS Exposure and Immune Response to Vaccination in Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing whether PFAS exposure alters the immune response to vaccination in adults; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Tetanus

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Innate Inflammatory Response, Vaccination | Phase 4 | Status: COMPLETED | Results posted: 2025-12-30